Elutia (ELUT) Capital Expenditures (2019 - 2026)
Elutia (ELUT) reported Capital Expenditures of $459000.0 for Q1 2026, up 65.11% on a YoY basis from $278000.0 in Q1 2025, and down 46.25% sequentially from $854000.0 in Q4 2025.
Elutia (ELUT) Capital Expenditures (2019 - 2026) Analysis & Trends
Elutia (ELUT) has 8 years of Capital Expenditures data on file, last reported at $459000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 65.11% year-over-year to $459000.0; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (up 124.32% YoY), and the FY2025 full-year result was $1.9 million, up 186.85% from the prior year.
- Capital Expenditures slipped to $459000.0 in Q1 2026, from $854000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $854000.0 in Q4 2025 to a low of -$2000.0 in Q2 2024.
- A 5-year average of $227941.2 and a median of $117000.0 in 2022 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures slumped 102.35% in 2024 and soared 5800.0% in 2025, its largest moves.
- Tracing ELUT's Capital Expenditures over 5 years: stood at $134000.0 in 2022, then sank by 87.31% to $17000.0 in 2023, then jumped by 452.94% to $94000.0 in 2024, then jumped by 808.51% to $854000.0 in 2025, then tumbled by 46.25% to $459000.0 in 2026.
- Business Quant data shows ELUT's Capital Expenditures at $459000.0 in Q1 2026, $854000.0 in Q4 2025, and $630000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.26 Bn | 176.96 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 47.53 Bn | 43.86 Bn | 1.29 Bn | 64.90 Mn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | 178.00 Mn |
| 7 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn | 76.60 Mn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.41 Bn | 2.07 Bn | -85.46 Mn |
| 10 | Elutia | 39.14 Mn | 10.65 Mn | 1.80 Mn | 459,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 459,000.00 |
| Mar 31, 2026 | 459,000.00 |
| Dec 31, 2025 | 854,000.00 |
| Dec 31, 2025 | 854,000.00 |
| Sep 30, 2025 | 630,000.00 |
| Sep 30, 2025 | 630,000.00 |
| Jun 30, 2025 | 114,000.00 |
| Jun 30, 2025 | 114,000.00 |
| Mar 31, 2025 | 278,000.00 |
| Mar 31, 2025 | 278,000.00 |
| Dec 31, 2024 | 94,000.00 |
| Dec 31, 2024 | 94,000.00 |
| Sep 30, 2024 | 547,000.00 |
| Sep 30, 2024 | 547,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | 15,000.00 |
| Mar 31, 2024 | 15,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Dec 31, 2023 | 17,000.00 |